The Beauty Health Company - SKIN STOCK NEWS

The Beauty Health Company (NASDAQ:SKIN), known for its Hydrafacial brand, is set to report its first quarter 2023 financial results before the market opens on May 10, 2023. An investor conference call will follow at 8:30 a.m. ET. This call is expected to provide insights into the company’s performance and strategic direction. Interested investors and analysts can participate via webcast, with a recording available shortly after the call. The company continues to focus on redefining skin health experiences globally, offering innovative products such as Hydrafacial, SkinStylus, and Keravive, and aims to positively impact communities and the planet.

The Beauty Health Company (NASDAQ: SKIN) has announced the promotion of Brad Hauser to the newly created position of Chief Operating Officer (COO). This role aims to enhance product oversight across the entire lifecycle, from innovation to market launch. Hauser, who joined the company in January 2023 as Chief Product Officer, will continue to lead the Product organization while taking on added responsibilities in Operations and Marketing.

His leadership is expected to bolster initiatives like the international launch of the Syndeo connected device, which has shown positive initial results. CEO Andrew Stanleick emphasized that Hauser's extensive industry experience will position the company to capitalize on growth opportunities more effectively.

The Beauty Health Company (NASDAQ: SKIN) has announced the launch of its second Hydrafacial Experience Center in Beijing, China. This facility will serve as a training hub for estheticians and a venue for hosting influencers and events. Located near a prominent landmark, the center aims to enhance BeautyHealth's presence in the competitive Chinese market. The opening event took place on April 14th, following the recent launch of the Hydrafacial Syndeo, a cutting-edge delivery system. President and CEO Andrew Stanleick highlighted the company's commitment to leveraging opportunities in China, stating Hydrafacial is positioned as the gold standard in the region. The Beijing center joins a global network of Hydrafacial Experience Centers and supports the educational program HFX, which has trained over 35,000 providers worldwide.

The Beauty Health Company (NASDAQ: SKIN) has launched the Hydrafacial™ Syndeo™ internationally after a successful U.S. introduction in March 2022. Syndeo combines Hydrafacial's patented vortex fusion technology with a cloud-based digital experience, allowing providers to personalize treatments based on client preferences and history. Over 3,000 Syndeo systems were sold in 2022, exceeding sales expectations. The product will debut at the Aesthetic & Anti-Aging Medicine World Congress in Monaco from March 30 to April 1, 2023, and will be available in select European and Asia-Pacific markets in April 2023.

The Beauty Health Company (NASDAQ: SKIN) reported a 41% year-over-year growth in net sales for 2022, reaching $365.9 million, exceeding market expectations for the eighth consecutive quarter. Adjusted EBITDA rose by 46% to $47.7 million, aligning with the previously guided range. For Q4 2022, net sales increased 26% year-over-year to $98.1 million, accompanied by a net income of $3.8 million. The company aims for 2023 net sales between $450 million to $470 million and confirms long-range 2025 guidance of $600 million to $700 million. Despite challenges, BeautyHealth's strategic focus on growth remains robust.

The Beauty Health Company (NASDAQ: SKIN) has entered a definitive agreement to acquire SkinStylus, an FDA-cleared microneedling device. This strategic acquisition aims to enhance BeautyHealth's portfolio as it strives to become a leading beauty, health, and wellness platform. Microneedling is expected to reach a U.S. market size of $1 billion by 2030 and is commonly offered alongside Hydrafacial treatments. The integration of SkinStylus is anticipated to provide opportunities for growth starting in 2024. Key opinions from company executives highlight the innovation and demand for microneedling in the aesthetic market.

Dior Beauty has partnered with The BeautyHealth Company (NASDAQ:SKIN) to launch a new exclusive experience called Dior powered by Hydrafacial. This treatment, debuting in April 2023 at Dior spas worldwide, combines Dior skincare with Hydrafacial technology. The 90-minute treatment incorporates the Dior Floral Peeling Lotion and Hydrafacial's patented vortex technology for enhanced skincare. BeautyHealth's CEO, Andrew Stanleick, highlighted the significance of this collaboration in creating innovative skincare experiences. This initiative aims to rejuvenate skin and promote wellness through effective treatment protocols.